Blood glucose lowering activity of aloe based composition, UP780, in alloxan induced insulin dependent mouse diabetes model

Diabetology and Metabolic Syndrome

Volumn 6, Issue 1, 2014, Pages

  Yimam, Mesfin ^a   Zhao, Jifu ^a   Corneliusen, Brandon ^a   Pantier, Mandee ^a   Brownell, Lidia ^a   Jia, Qi ^a  

^a Unigen Inc   (United States)

Author keywords

Alloxan; Aloe vera; Chromones; Insulin resistance

Indexed keywords

ALLOXAN; ALOE VERA EXTRACT; CHROMONE ALOESIN; EMODIN; GLIBENCLAMIDE; GLUCOSE; INSULIN; POLYSACCHARIDE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UP 780;

ALLOXAN-INDUCED DIABETES MELLITUS; ALOE; ALOE VERA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; FEMALE; GEL; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; POWDER; PRIORITY JOURNAL;

EID: 84901981712     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-6-61     Document Type: Article

References (37)

1. Cohen IK, Diegelmann RF, Lindblad WJ, Wound Healing: Biochemical & Clinical Aspects Philadelphia: Saunders 1992
2. The Aloe vera phenomenon: a review of the properties and modern uses of the leaf parenchyma gel. Grindlay D, Reynolds T, J Ethnopharmacol 1986 16 117 151 10.1016/0378-8741(86)90085-1 3528673
3. Two functionally and chemically distinct immunomodulatory compounds in the gel of Aloe vera. Hart LA, van Enckevort PH, van Dijk H, Zaat R, de Silva KT, Labadie RP, J Ethnopharmacol 1988 23 61 71 10.1016/0378-8741(88)90115-8 2843719
4. Inhibition of mushroom-tyrosinase by aloe extract. Yagi A, Kanbara T, Morinobu N, Planta Med 1987 53 515 517 10.1055/s-2006-962798 17269093 (Pubitemid 18004288)
5. Yu BP, Lee KY, Identification of potent antioxidant from Aloe barbadensis U.S. Patent No. 5, 939, 395
6. Effect of aloes on blood glucose levels in normal and alloxan diabetic mice. Ajabnoor MA, J Ethnopharmacol 1990 28 215 220 10.1016/0378-8741(90)90031-N 2109811 (Pubitemid 20086039)
7. The antidiabetic activity of aloes: preliminary clinical and experimental observations. Ghannam N, Kingston M, Al-Meshaal IA, Tariq M, Parman NS, Woodhouse N, Horm Res 1986 24 288 294 10.1159/000180569 3096865 (Pubitemid 16004133)
8. Modulation of melanogenesis by aloesin: a competitive inhibitor of tyrosinase. Jones K, Hughes J, Hong M, Jia Q, Orndorff S, Pigment Cell Res 2002 15 335 340 10.1034/j.1600-0749.2002.02014.x 12213089
9. Aloesin up-regulates cyclin E/CDK2 kinase activity via inducing the protein levels of cyclin E, CDK2, and CDC25A in SK-HEP-1 cells. Lee KY, Park JH, Chung MH, Park YI, Kim KW, Lee YJ, Lee SK, Biochem Mol Biol Int 1997 41 285 292 9063568 (Pubitemid 28172133)
10. Antiinflammatory C-glucosyl chromone from Aloe barbadensis. Hutter JA, Salman M, Stavinoha WB, Satsangi N, Williams RF, Streeper RT, Weintraub ST, J Nat Prod 1996 59 541 543 10.1021/np9601519 8778246 (Pubitemid 26161086)
11. Isolation and identification of a phenolic antioxidant from Aloe barbadensis. Lee KY, Weintraub ST, Yu BP, Free Radic Biol Med 2000 28 261 265 10.1016/S0891-5849(99)00235-X 11281293 (Pubitemid 30084018)
12. Rat model of food-induced non-obese-type 2 diabetes mellitus: comparative pathophysiology and histopathology. Adeyi AO, Idowu BA, Mafiana CF, Oluwalana SA, Ajayi OL, Akinloye OA, Int J Physiol Pathophysiol Pharmacol 2012 4 51 58 22461957
13. The antidiabetic activity of total lignan from Fructus Arctii against alloxan-induced diabetes in mice and rats. Xu Z, Wang X, Zhou M, Ma L, Deng Y, Zhang H, Zhao A, Zhang Y, Jia W, Phytother Res 2008 22 97 101 10.1002/ptr.2273 17724763 (Pubitemid 351155920)
14. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, Pugh W, Rue PA, Polonsky KS, Yuan CS, Diabetes 2002 51 1851 1858 10.2337/diabetes.51.6.1851 12031973 (Pubitemid 34564298)
15. Rosemary (Rosmarinus officinalis L.) leaf extract limits weight gain and liver steatosis in mice fed a high-fat diet. Harach T, Aprikian O, Monnard I, Moulin J, Membrez M, Beolor JC, Raab T, Mace K, Darimont C, Planta Med 2010 76 566 571 10.1055/s-0029-1240612 19918713
16. Antioxidant effect of Aloe vera gel extract in streptozotocin-induced diabetes in rats. Rajasekaran S, Sivagnanam K, Subramanian S, Pharmacol Rep 2005 57 90 96 15849382 (Pubitemid 40601546)
17. Beneficial effects of aloe vera leaf gel extract on lipid profile status in rats with streptozotocin diabetes. Rajasekaran S, Ravi K, Sivagnanam K, Subramanian S, Clin Exp Pharmacol Physiol 2006 33 232 237 10.1111/j.1440-1681. 2006.04351.x 16487267
18. The effect of a plants mixture extract on liver gluconeogenesis in streptozotocin induced diabetic rats. al-Awadi F, Fatania H, Shamte U, Diabetes Res 1991 18 163 168 1842751
19. Modulatory effects of Aloe vera leaf gel extract on oxidative stress in rats treated with streptozotocin. Rajasekaran S, Sivagnanam K, Subramanian S, J Pharm Pharmacol 2005 57 241 246 10.1211/0022357055416 15720789 (Pubitemid 40129093)
20. Susceptibility of hippocampus and cerebral cortex to oxidative damage in streptozotocin treated mice: prevention by extracts of Withania somnifera and Aloe vera. Parihar MS, Chaudhary M, Shetty R, Hemnani T, J Clin Neurosci 2004 11 397 402 10.1016/j.jocn.2003.09.008 15080956 (Pubitemid 38568479)
21. Effect of Aloe vera (L.) Burm. fil. leaf gel and pulp extracts on kidney in type-II diabetic rat models. Bolkent S, Akev N, Ozsoy N, Sengezer-Inceli M, Can A, Alper O, Yanardag R, Indian J Exp Biol 2004 42 48 52 15274480 (Pubitemid 38065767)
22. Effect of Aloe vera leaf gel and pulp extracts on the liver in type-II diabetic rat models. Can A, Akev N, Ozsoy N, Bolkent S, Arda BP, Yanardag R, Okyar A, Biol Pharm Bull 2004 27 694 698 10.1248/bpb.27.694 15133247 (Pubitemid 41694673)
23. Hypoglycemic and hypolipidemic effects of processed Aloe vera gel in a mouse model of non-insulin-dependent diabetes mellitus. Kim K, Kim H, Kwon J, Lee S, Kong H, Im SA, Lee YH, Lee YR, Oh ST, Jo TH, Park YI, Lee CK, Kim K, Phytomedicine 2009 16 856 863 10.1016/j.phymed.2009.02.014 19303272
24. UP780, a chromone-enriched aloe composition improves insulin sensitivity. Yimam M, Zhao J, Corneliusen B, Pantier M, Brownell LA, Jia Q, Metab Syndr Relat Disord 2013 11 267 275 10.1089/met.2012.0135 23573999
25. Identification of five phytosterols from Aloe vera gel as anti-diabetic compounds. Tanaka M, Misawa E, Ito Y, Habara N, Nomaguchi K, Yamada M, Toida T, Hayasawa H, Takase M, Inagaki M, Higuchi R, Biol Pharm Bull 2006 29 1418 1422 10.1248/bpb.29.1418 16819181
26. Prevention of atheromatous heart disease. Agarwal OP, Angiology 1985 36 485 492 10.1177/000331978503600801 2864002 (Pubitemid 15227824)
27. Antidiabetic activity of Aloe vera L. juice. I. Clinical trial in new cases of diabetes mellitus. Yongchaiyudha S, Rungpitarangsi V, Bunyapraphatsara N, Chokechaijaroenporn O, Phytomedicine 1996 3 241 243 10.1016/S0944-7113(96) 80060-2 23195077 (Pubitemid 126504564)
28. Antidiabetic activity of Aloe vera L. juice II. Clinical trial in diabetes mellitus patients in combination with glibenclamide. Bunyapraphatsara N, Yongchaiyudha S, Rungpitarangsi V, Chokechaijaroenporn O, Phytomedicine 1996 3 245 248 10.1016/S0944-7113(96)80061-4 23195078 (Pubitemid 126504565)
29. Effect of aloe on hyperlipidemia in patients with negative response to diet. Nasiff HA, Fajardo FR, Velez F, Revista Cubana Med Gen Integral 1993 9 43 51
30. Effects of Aloe vera supplementation in subjects with prediabetes/metabolic syndrome. Devaraj S, Yimam M, Brownell LA, Jialal I, Singh S, Jia Q, Metab Syndr Relat Disord 2013 11 35 40 10.1089/met.2012.0066 23035844
31. Anti-hyperglycemic and anti-hypercholesterolemic effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Huseini HF, Kianbakht S, Hajiaghaee R, Dabaghian FH, Planta Med 2012 78 311 316 10.1055/s-0031-1280474 22198821
32. Pancreatic beta-cell neogenesis by direct conversion from mature alpha-cells. Chung CH, Hao E, Piran R, Keinan E, Levine F, Stem Cells 2010 28 1630 1638 10.1002/stem.482 20653050
33. Effect of Aloe vera leaves on blood glucose level in type I and type II diabetic rat models. Okyar A, Can A, Akev N, Baktir G, Sutlupinar N, Phytother Res 2001 15 157 161 10.1002/ptr.719 11268118 (Pubitemid 32290488)
34. Exposure to glibenclamide increases rat beta cells sensitivity to glucose. Patanè G, Piro S, Anello M, Rabuazzo AM, Vigneri R, Purrello F, Br J Pharmacol 2000 129 887 892 10.1038/sj.bjp.0703131 10696086 (Pubitemid 30142899)
35. Radical-scavenging effects of Aloe arborescens Miller on prevention of pancreatic islet B-cell destruction in rats. Beppu H, Koike T, Shimpo K, Chihara T, Hoshino M, Ida C, Kuzuya H, J Ethnopharmacol 2003 89 37 45 10.1016/S0378-8741(03)00268-X 14522430 (Pubitemid 37163797)
36. Aloe vera gel alleviates cardiotoxicity in streptozocin-induced diabetes in rats. Jain N, Vijayaraghavan R, Pant SC, Lomash V, Ali M, J Pharm Pharmacol 2010 62 115 123 10.1211/jpp.62.01.0013 20723007
37. The mechanisms of alloxan- and streptozotocin-induced diabetes. Lenzen S, Diabetologia 2008 51 216 226 10.1007/s00125-007-0886-7 18087688